Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2012
11/27/2012US8318944 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/27/2012US8318779 Lysine related derivatives as HIV aspartyl protease inhibitors
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318742 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/27/2012US8318737 Compounds and compositions for treating cancer
11/27/2012US8318721 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/27/2012US8318706 Substituted tetracycline compounds
11/27/2012US8318443 Reagent for detecting an analyte
11/27/2012US8318184 MGLU2 agonists
11/27/2012CA2569849C Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts
11/22/2012WO2012157776A1 Acrylamide aqueous solution, stabilization agent for acrylamide aqueous solution, and stabilization method for acrylamide aqueous solution
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012US20120296094 Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same
11/22/2012US20120295910 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
11/22/2012US20120294901 Novel cochleate formulations
11/22/2012US20120294804 Phenylethanolamine-based nmda receptor antagonists
11/22/2012CA2836311A1 Amine derivatives as potassium channel blockers
11/21/2012EP2524912A1 Amine derivatives
11/21/2012EP2523936A1 Compounds which modulate the cb2 receptor
11/21/2012CN102391173B Cilnidipine compound and preparation method thereof
11/21/2012CN102127005B Intermediate of alvimopan and synthesis method thereof
11/21/2012CN101648902B Dihydropyridine type tumor chemotherapeutic sensitizer and application thereof
11/21/2012CN101602708B Aryl alkanol piperidine derivative and application thereof as antidepressive medicine
11/20/2012US8314244 Method for preparing activated esters
11/20/2012US8314243 Process for catalytically preparing aromatic or heteroaromatic nitriles
11/20/2012US8314233 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
11/20/2012US8314155 Bicyclic aromatic sulfinyl derivatives
11/20/2012US8314148 Selective hydroxamate based MMP inhibitors
11/20/2012US8314127 Piperidine derivatives
11/20/2012US8314126 Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
11/20/2012US8314097 Organic compounds
11/15/2012WO2012153950A2 Method for preparing t-butyl 2-((4r,6s)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate
11/15/2012US20120289548 Oligomer-opioid agonist conjugates
11/15/2012US20120289527 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/15/2012US20120289518 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/15/2012US20120289403 Fluorinated Oxa or Thia Heteroarylalkylsulfide Derivatives for Combating Invertebrate Pests
11/15/2012US20120288555 Antiproliferative compositions comprising curcumin analogs and methods of producing and using same
11/15/2012US20120287354 Electro-optical light control element, display and medium
11/15/2012US20120286251 Novel compound and organic light-emitting device including the same
11/15/2012US20120285538 Dye compound, dye-sensitized solar cell using the same and dye solution
11/14/2012EP2521714A1 Sulfone compounds as 5-ht6 receptor ligands
11/14/2012CN102781917A Sterically hindered amines
11/14/2012CN102781916A Compounds as bradykinin B1 antagonists
11/14/2012CN102775343A Preparation method for 1-N-BOC-4-acetyl piperidine
11/14/2012CN102015645B Piperidine and pyrrolidine compounds
11/14/2012CN101812055B Compound and method applying same for fluorescence detection of activity of monoamine oxidase
11/14/2012CN101522621B Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo [1,5-a] pyrimidine derivatives using same
11/14/2012CN101497583B Process for the preparation of 4-amino-2,2,6,6-tetramethylpiperidine
11/14/2012CN101394831B Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions
11/14/2012CN101321730B Cyclopropyl amines as modulators of the histamine H3 receptor
11/13/2012US8309740 One-pot synthesis of fluorinated ionic liquids
11/13/2012US8309732 Process for preparing quaternary salts of piperidyl esters of mandelic acid
11/13/2012US8309720 Process for the preparation of substituted pyrimidine derivatives
11/13/2012US8309715 Camphor-derived β-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same
11/13/2012US8309597 1,1′-diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/13/2012US8309596 Kallikrein 7 modulators
11/13/2012US8309579 N-hydroxyamide derivatives and use thereof
11/13/2012CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
11/13/2012CA2505299C Novel biaromatic compunds which activate ppary type receptors, and use therof in cosmetic or pharmaceutical compositions
11/08/2012US20120283445 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
11/08/2012US20120283287 Certain chemical entities, compositions, and methods
11/08/2012US20120283266 Lysine specific demethylase-1 inhibitors and their use
11/08/2012US20120283194 Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
11/08/2012US20120283137 Mass labels
11/08/2012US20120282629 Enhancers of Protein Degradation
11/08/2012US20120282548 Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition and resist film
11/07/2012EP2520568A1 Spirocyclic nitriles as inhibitors of protease
11/07/2012CN101874020B Piperidine derivatives as agonists of muscarinic receptors
11/07/2012CN101466349B Piperidinium compounds and cosmetic compositions containing them
11/07/2012CN101448802B Acrylamide derivative as histone deacetylase inhibitors for cancer treatment
11/06/2012US8304552 Fatty acid niacin conjugates and their uses
11/06/2012US8304551 Fatty acid niacin conjugates and their uses
11/06/2012US8304547 Azolecarboxamide compound or salt thereof
11/06/2012US8304435 Deuterium-enriched donepezil
11/06/2012US8304433 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
11/06/2012US8304432 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
11/06/2012US8304431 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012US8304403 Heterocyclic CETP inhibitors
11/06/2012CA2563269C Process for producing cyclic n-hydroxy imide compounds
11/01/2012WO2012146515A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012US20120277438 Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
11/01/2012US20120277250 Amidine-containing compounds useful as muscarinic receptor antagonists
11/01/2012US20120277221 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
11/01/2012US20120276018 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012CA2834467A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
10/2012
10/31/2012EP2516392A1 Substituted benzamide derivatives
10/31/2012CN102757382A Purification method of fexofenadine intermediate
10/31/2012CN102757381A Method for preparing donepezil
10/31/2012CN102757380A Effective synthesizing method of piperidine and piperazine derivatives with alkyl chains
10/31/2012CN102757379A Preparation method of alvimopan
10/31/2012CN102757300A Benzophenanthrene derivative, preparation method and light emitting device made thereof
10/31/2012CN101711236B N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/31/2012CN101538311B Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof
10/30/2012US8299279 Semi-synthetic process for the preparation of taxane derivatives
10/30/2012US8299267 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
10/30/2012US8299259 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/30/2012US8299258 Method of making piperidine derivatives
10/30/2012US8299243 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
10/30/2012US8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 380